Despite warning, doctors stick with patch

Aug 28, 2007

Many doctors are overlooking Food and Drug Administration warnings about delivering the painkiller fentanyl through a skin patch.

In 2005, after the opium-like drug killed a number of patients, the FDA issued a warning that said the painkiller in patch form should be prescribed in low doses and was not be used for patients recovering from surgery, the Los Angeles Times reported Monday.

But since then hundreds of patients have died because healthcare providers have not gotten the message, and prescriptions of the patch did not decrease after the warning was issued.

The problem is even more pressing because a number of other drugs are beginning to be available in patch form, the newspaper said. Though patches can be an easier way to administer drugs, it is more difficult to make sure patients with widely varying body chemistry get the right amount at the right time.

Ortho-McNeil, which makes the brand name form of the drug, called Duragesic, told the Times it would support efforts to make sure the product is used safely.

Copyright 2007 by United Press International

Explore further: Sperm bank sued after donor details emerge 7 years later

Related Stories

Materials scientists turn to collagen

Jun 05, 2014

(Phys.org) —Miniature scaffolds made from collagen – the 'glue' that holds our bodies together – are being used to heal damaged joints, and could be used to develop new cancer therapies or help repair ...

Secrets from the deep

Nov 21, 2013

Violent bursts of organic matter from dying organisms, continuous showers of "marine snow" from the upper layers of a water column, and nutrients leaking from creatures so tiny they are invisible to the naked ...

Recommended for you

Cardinal Health paying $26.8 million in FTC settlement

14 hours ago

Cardinal Health will pay $26.8 million as part of a settlement with the Federal Trade Commission over charges it monopolized the sale in 25 markets of diagnostic drugs known as low-energy radiopharmaceuticals.

Selecting the right tool for the job

Apr 14, 2015

Randomized clinical trials of new drugs have long been considered the "gold standard" in determining safety and efficacy before drugs, biologics, vaccines or devices are introduced to the general public. However, in the case ...

User comments : 0

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.